insights_auto
Kwa nini ORX imepungua kwa 3.58%?
Fahamu zaidichevron_right
ORX:STO
Orexo AB
SEK 0.84
arrow_downward
-3.58%(-0.031) Siku 1
13 Nov, 15:13:16 GMT +1 · SEK
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ORX...
Fungua
SEK 0.90
Juu
SEK 0.90
Chini
SEK 0.83
Mtaji wa soko
291.96M
Wastani wa kiasi cha mauzo
elfu 739.90
Kiasi cha mauzo ya hisa
elfu 839.93
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.06
Juu kwa wiki 52
SEK 22.55
Chini kwa wiki 52
SEK 0.80
EPS
SEK 13.61
Hisa za wawekezaji
35.13M
Idadi ya wafanyakazi
55
Fungua
SEK 0.90
Juu
SEK 0.90
Chini
SEK 0.83
Mtaji wa soko
291.96M
Wastani wa kiasi cha mauzo
elfu 739.90
Kiasi cha mauzo ya hisa
elfu 839.93
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.06
Juu kwa wiki 52
SEK 22.55
Chini kwa wiki 52
SEK 0.80
EPS
SEK 13.61
Hisa za wawekezaji
35.13M
Idadi ya wafanyakazi
55
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ChartMill
·
dakika 39 zilizopita
S&P 500 Premarket Movers: Travelers, Palo Alto Networks Gain; Cisco, AMD Fall
The Motley Fool
·
saa 1 iliyopita
The S&P 500 Recently Experienced Its Worst Day Since 2025. Here's Why Investors Shouldn't Worry.
FOREX.com
·
saa 2 zilizopita
S&P 500 forecast: SPX struggles for direction ahead of PPI data
Investing.com
·
saa 1 iliyopita
Goldman’s Oppenheimer sees S&P 500 advancing to 8,700 in 2027
Wasifu
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Kuhusu Orexo AB
Afisa Mkuu Mtendaji (CEO)Nikolaj Sørensen
Wafanyakazi55
Lilianzishwa1995
Makao makuu-
SektaHealth Care
Sekta-
Tovutiorexo.com